Blog

March 30, 2024

2nd March Newsletter

Featured Portfolio

The Multi-Patient Ventilator offers seamless scalability and adaptability for diverse medical conditions and emergencies. With precise ventilator control and physical separation features, it ensures tailored ventilation support while reducing the risk of infections. This innovative system revolutionizes respiratory support, empowering healthcare providers to respond effectively to critical situations.

TOP STORIES
PATENTS AND TECHNOLOGY

Sona Nanotech Announces Filing of Provisional Patent Application

by Stockhouse in March ‘24

Sona Nanotech (CSE: SONA) is making strides in innovation with its latest move: the submission of a provisional patent application to the U.S. Patent and Trademark Office. This application is for their groundbreaking proprietary photothermal light device.

L-Nutra Health® Pioneers New, Innovative Therapeutic Healthcare Model with Official Diabetes Patent

by PR Newswire in March ‘24

L-Nutra Health® secured the first U.S. patent for type 2 diabetes remission using cellular reprogramming, marking a significant advance in nutrition technology. This milestone reinforces L-Nutra Health®’s leadership in science-driven nutrition solutions.

TOP STORIES
HEALTHCARE TRANSACTIONS

Lawsuit claims Boehringer misused US patents to delay asthma-drug rivals

by Reuters in March ‘24 

Boehringer Ingelheim, a German pharmaceutical firm, was sued in Boston for allegedly using patents to delay generic competition and inflate prices for lung disease drugs Combivent Respimat and Spiriva Respimat.

Viatris generic hypertension drug does not violate J&J patents, US court says

by Reuters in March ‘24 

Viatris (VTRS.O), a generic drugmaker, has won a legal battle in West Virginia, convincing a federal judge that its proposed generic version of Johnson & Johnson’s (JNJ.N) cardiovascular drug Veletri doesn’t infringe J&J’s patents.

 

RECENTLY
ISSUED PATENTS

Cyclo Therapeutics secures patent for Alzheimer's treatment

by Investing.com Australia in March ‘24

Cyclo Therapeutics, Inc. (NASDAQ: CYTH) has secured a U.S. patent for Trappsol® Cyclo™, their pioneering treatment for early onset Alzheimer’s disease. The patent, titled “Methods for Treating Alzheimer’s Disease,” highlights the company’s dedication to advancing therapies for this condition.

 

HeartBeam secures new patents for cardiac monitoring technology

by Medical Device Network in March ‘24
HeartBeam’s watch device is designed to combine continuous electrocardiogram (ECG) monitoring with the ability to capture a 12-lead ECG.

CURRENT PORTFOLIO AVAILABLE FOR SALE
AND LICENSE WITH HIGH INTEREST

Rapid Recovery is a a powerful antioxidant blend crafted to combat oxidative stress and promote overall well-being. With its strategic formulation, it works to support liver health, enhance energy levels, and alleviate stress symptoms for a revitalized you.

Newsletter
About peter

Created with Visual Composer